ask="6.10"
ask_size="3200"
average_daily_volume="442087"
bid="5.90"
bid_size="300"
book_value="1.85"
change="-0.15"
change_from_200_day_moving_average="-2.23"
change_from_50_day_moving_average="-1.77"
change_from_52_week_high="-12.62"
change_From_52_week_low="0.15"
change_in_percent="-2.40%"
close="6.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.68"
ebitda="-116.64M"
eps_estimate_current_year="-1.62"
eps_estimate_next_quarter="-0.34"
eps_estimate_next_year="-1.43"
ex_dividend_date="N/A"
float_shares="40949000"
high="6.25"
high_52_weeks="18.72"
last_trade_date="1/30/2017"
last_trade_price="6.10"
last_trade_size="11869"
last_trade_time="4:00pm"
low="6.00"
low_52_weeks="5.95"
market_capitalization="529.36M"
moving_average_200_day="8.33"
moving_average_50_day="7.87"
name="NovoCure Limited"
notes="N/A"
one_year_target_price="23.25"
open="6.25"
pe_ratio="N/A"
peg_ratio="-0.06"
percent_change_from_200_day_moving_average="-26.74%"
percent_change_from_50_day_moving_average="-22.47%"
percent_change_from_52_week_high="-67.41%"
percent_change_from_52_week_low="+2.52%"
previous_close="6.25"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.39"
price_per_sales="8.34"
revenue="65.03M"
shares_outstanding="86780000"
short_ratio="8.05"
stock_exchange="NMS"
symbol="NVCR"
volume="168934"
weeks_range_52="5.95 - 18.72"
